You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Adenocarcinoma, Papillary

Showing 1 - 25 of 2,443
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Thyroglobulin and Galectin-3 for Prognosis and Follow-up in

Recruiting
  • Thyroid Cancer
  • +2 more
    • Taipei, Taiwan
      Chih-Yuan Wang, M.D
    Oct 16, 2022

    Studies on Tumors of the Thyroid

    Recruiting
    • Hurthle Cell Thyroid Cancer
    • +4 more
    • 68-Gallium Dotatate
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 26, 2023

    Pancreatic Cyst, Pancreatic Tumors, Pancreatic Cancer Trial in San Francisco (Survey)

    Recruiting
    • Pancreatic Cyst
    • +7 more
    • Survey
    • San Francisco, California
      University of California, San Francisco
    Sep 20, 2022

    18F-TFB PET/CT Scan in Differentiated Thyroid Cancer

    Recruiting
    • Differentiated Thyroid Gland Carcinoma
    • +2 more
    • Computed Tomography
    • +3 more
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Jan 4, 2023

    Thyroid Cancer, Thyroid Carcinoma, Metastatic Thyroid Cancer Trial in Boston (Selpercatinib, Sodium Iodine I-131, rhTSH)

    Not yet recruiting
    • Thyroid Cancer
    • +5 more
    • Boston, Massachusetts
      Massachusetts General Hospital
    Dec 20, 2022

    Refractory Thyroid Gland Carcinoma, Refractory Thyroid Gland Papillary Carcinoma, Refractory Thyroid Gland Follicular Carcinoma

    Recruiting
    • Refractory Thyroid Gland Carcinoma
    • +3 more
    • 177Lu-DOTA-EB-FAPI 1 radionuclide therapy
    • +2 more
    • Xiamen, China
      The First Affiliated Hospital of Xiamen University
    Nov 3, 2022

    Columnar Cell Variant Thyroid Gland Papillary Carcinoma, Follicular Variant Thyroid Gland Papillary Carcinoma, Metastatic

    Active, not recruiting
    • Columnar Cell Variant Thyroid Gland Papillary Carcinoma
    • +25 more
    • Laboratory Biomarker Analysis
    • +3 more
    • Torrance, California
    • +6 more
    Jan 12, 2023

    Acinar Cell Carcinoma, Ampulla of Vater Adenocarcinoma, Cholangiocarcinoma Trial in Cleveland, Philadelphia (Pancreatectomy,

    Recruiting
    • Acinar Cell Carcinoma
    • +7 more
    • Pancreatectomy
    • Lavage
    • Cleveland, Ohio
    • +1 more
    Sep 7, 2022

    Renal Clear Cell Carcinoma, Renal Papillary Cell Carcinoma Trial in London (Savolitinib, MEDI4736, Tremelimumab)

    Active, not recruiting
    • Renal Clear Cell Carcinoma
    • Renal Papillary Cell Carcinoma
    • London, United Kingdom
      Thomas Powles
    Aug 10, 2022

    Ovarian Brenner Tumor, Ovarian Carcinosarcoma, Ovarian Clear Cell Cystadenocarcinoma Trial in Canada, Singapore, United States

    Active, not recruiting
    • Ovarian Brenner Tumor
    • +11 more
    • Duarte, California
    • +15 more
    Aug 11, 2022

    Thyroid Cancer, Thyroid Cancer, Follicular, Papillary Thyroid Cancer Trial in United States (Trametinib, Dabrafenib, PDR001)

    Recruiting
    • Thyroid Cancer
    • +6 more
    • Basking Ridge, New Jersey
    • +6 more
    Jan 19, 2023

    Hereditary Pancreatic Carcinoma, Pancreatic Adenocarcinoma, Pancreatic Intraductal Papillary-Mucinous Tumor Trial in Portland

    Recruiting
    • Hereditary Pancreatic Carcinoma
    • +2 more
    • Dynamic Contrast-Enhanced Magnetic Resonance Imaging
    • Ferumoxytol
    • Portland, Oregon
      OHSU Knight Cancer Institute
    Aug 16, 2022

    RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET-altered Papillary Thyroid Cancer Trial in Worldwide

    Active, not recruiting
    • RET-altered Non Small Cell Lung Cancer
    • +39 more
    • pralsetinib (BLU-667)
    • Phoenix, Arizona
    • +65 more
    Nov 10, 2022

    Solid Tumor, Non Small Cell Lung Cancer, Pancreatic Cancer Trial in Israel, United States (CM-24 and Nivolumab - Dose

    Recruiting
    • Solid Tumor
    • +6 more
    • CM-24 and Nivolumab - Dose Escalation
    • +4 more
    • Scottsdale, Arizona
    • +10 more
    Jan 17, 2023

    oncRNA Stratification of Cancer by Size and Stage

    Not yet recruiting
    • Kidney Cancer
    • +32 more
    • Exai oncRNA blood test
    • (no location specified)
    Apr 27, 2023

    Thyroid Cancer, Thyroid Cancer, Medullary, Differentiated Thyroid Cancer Trial in Tampa (Lenvatinib, Sorafenib, Cabozantinib)

    Terminated
    Has Results
    • Thyroid Cancer
    • +5 more
    • Tampa, Florida
      H. Lee Moffitt Cancer Center and Research Institute
    Jul 12, 2021

    Adenoid Cystic Skin Carcinoma, Adnexal Carcinoma, Anaplastic Large Cell Lymphoma, ALK-Negative Trial in United States

    Recruiting
    • Adenoid Cystic Skin Carcinoma
    • +38 more
    • Biopsy
    • +6 more
    • Los Angeles, California
    • +35 more
    Jan 31, 2023

    Kidney Cancer, Renal Cell Carcinoma, Clear Cell Carcinoma Trial in Dallas (13C-Glucose, 13C-Acetate, 13C-Lactate)

    Recruiting
    • Kidney Cancer
    • +11 more
    • 13C-Glucose
    • +4 more
    • Dallas, Texas
      University of Texas Southwestern Medical Center
    Dec 1, 2022

    Metastatic Thyroid Papillary Carcinoma, Metastatic Thyroid Follicular Carcinoma, Metastatic Thyroid Cancer Trial in Spain

    Recruiting
    • Metastatic Thyroid Papillary Carcinoma
    • +2 more
    • L'Hospitalet de Llobregat, Barcelona, Spain
    • +14 more
    Feb 18, 2022

    Differentiated Thyroid Gland Carcinoma, Thyroid Gland Follicular Carcinoma, Thyroid Gland Papillary Carcinoma Trial in Atlanta

    Terminated
    • Differentiated Thyroid Gland Carcinoma
    • +2 more
    • Atlanta, Georgia
      Emory University Hospital/Winship Cancer Institute
    Jun 25, 2021

    Ovarian Endometrioid Adenocarcinoma, Ovarian Seromucinous Carcinoma, Ovarian Serous Cystadenocarcinoma Trial in Jacksonville,

    Completed
    Has Results
    • Ovarian Endometrioid Adenocarcinoma
    • +8 more
    • Jacksonville, Florida
    • +1 more
    Sep 28, 2020

    Synthetic Thyroid Hormone for Thyroid Cancer Treatment

    Completed
    • Malignant Struma Ovarii
    • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Sep 25, 2020

      Papillary Thyroid Cancer, Follicular Thyroid Cancer, Differentiated Thyroid Cancer Trial in Washington (SU011248, Sutent)

      Completed
      Has Results
      • Papillary Thyroid Cancer
      • +2 more
      • SU011248, Sutent
      • Washington, District of Columbia
        MedStar Washington Hospital Center
      Aug 3, 2020

      Thyroid Tumors Trial in Lexington (Lenalidomide)

      Completed
      Has Results
      • Thyroid Neoplasms
      • Lexington, Kentucky
        University of Kentucky Markey Cancer Center
      May 28, 2020

      Refractory Differentiated Thyroid Gland Carcinoma, Refractory Thyroid Gland Follicular Carcinoma, Refractory Thyroid Gland

      Completed
      Has Results
      • Refractory Differentiated Thyroid Gland Carcinoma
      • +4 more
      • Duarte, California
      • +32 more
      Jun 24, 2021